Substance Name: Ustekinumab [USAN:INN:BAN:JAN]
RN: 815610-63-0
UNII: FU77B4U5Z0
Notes
- A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.
- May prove useful in treating psoriasis.
Molecular Formula
- Unspecified
Classification Codes
- Dermatologic Agents
- Treatment of Immunologically Mediated Inflammatory Disorders
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Ustekinumab
- Ustekinumab [USAN:INN:BAN:JAN]
MeSH Heading
- Ustekinumab
Synonyms
- CNTO 1275
- CNTO1275
- Immunoglobulin G1, anti-(human interleukin-12 subunit beta (IL-12B, CLMF p40, NKSF2)) (human monoclonal CNTO 1275 gamma1-chain), disulfide with human monoclonal CNTO 1275 kappa-chain, dimer
- Stelara
- UNII-FU77B4U5Z0
- Ustekinumab
Systematic Name
- Immunoglobulin G1, anti-(human interleukin 12 p40 subunit) (human monoclonal CNTO 1275 gamma1-chain), disulfide with human monoclonal CNTO 1275 kappa-chain, dimer
Registry Numbers
CAS Registry Number
- 815610-63-0
FDA UNII
- FU77B4U5Z0
Other Registry Number
- 949907-93-1
System Generated Number
- 0815610630